Engineered CAR-T Cells Target Amyloid Plaques in Alzheimer's Brain
Researchers have successfully modified CD4+ T cells with chimeric antigen receptors (CARs) to specifically recognize and target amyloid-β plaques…
Found 2029 results for "cancer"
Researchers have successfully modified CD4+ T cells with chimeric antigen receptors (CARs) to specifically recognize and target amyloid-β plaques…
Parasitic wasps deploy a viral-derived protein tyrosine phosphatase that specifically targets Rad9A, a critical cell cycle checkpoint protein, effectively…
Medical experts are raising concerns about potential policy changes that could weaken universal hepatitis B vaccination for newborns, currently recommended by…
An international expert panel has established the first formal clinical definitions and assessment frameworks for loneliness specifically in older cancer…
Mouse studies reveal that cystatin-C, a protein released by certain tumors, penetrates the blood-brain barrier and activates microglia cells to break down…
Talazoparib, a PARP1 inhibitor used in cancer therapy, demonstrates the strongest senescence-inducing activity among tested PARP inhibitors in lung cancer…
Cardiac toxicity emerges as a critical limitation for immune checkpoint inhibitors like pembrolizumab and nivolumab, with researchers now identifying the…
Nordihydroguaiaretic acid (NDGA), a lignin compound from creosote bush, demonstrates significantly enhanced anti-cancer activity against prostate tumors when…
A computational framework successfully distinguishes between benign and pathogenic single amino acid substitutions in proteins, addressing a critical gap in…
The ATR/CHK1 signaling cascade can initiate genome protection responses even when stripped of RPA protein complexes, traditionally considered essential for…
Clinical trial data reveals that time-limited chronic lymphocytic leukemia treatment produces equivalent survival outcomes compared to indefinite therapy…
Nondaily and low-intensity smokers in Latin America present distinct cessation challenges that differ markedly from heavy daily users. These lighter smoking…
Marcel Deckert's team at INSERM Nice has identified USP9X as a critical vulnerability in melanoma progression, where this deubiquitinating enzyme stabilizes…
Nivolumab, a PD-1 checkpoint inhibitor, demonstrates remarkable durability in advanced melanoma patients with survival benefits persisting nearly a decade…
Scientists have engineered circular RNA structures that form self-looping configurations, demonstrating enhanced stability and prolonged therapeutic activity…
Recent trial data indicates that biparametric MRI (bpMRI), which uses only two imaging sequences instead of the standard three or more, demonstrates…
The PRIME trial found that biparametric MRI (bpMRI) performs equivalently to the standard multiparametric MRI (mpMRI) for detecting clinically significant…
The PRIME clinical trial establishes that biparametric MRI (bpMRI) achieves equivalent diagnostic performance to multiparametric MRI (mpMRI) for identifying…
Ten patients with severe, treatment-resistant autoimmune conditions—five with antisynthetase syndrome and five with systemic sclerosis—experienced significant…
A population-based screening trial involving over 270,000 Swedish adults demonstrated that both colonoscopy and fecal immunochemical testing (FIT)…